Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Daga

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Cancer|January 21, 2014
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.
International Journal of Cancer|December 12, 2018
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastomaLindi Chen, Fabio Pastorino, Philip Berry, et al.
International Journal of Cancer|August 6, 2014
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.
BMC Cancer|April 18, 2015
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsFederica Barbieri, Stefano Thellung, Alessandra Ratto, et al.
The Journal of Biological Chemistry|January 17, 2009
Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitorsFabrizio Griffero, Antonio Daga, Daniela Marubbi, et al.
Plos One|January 24, 2012
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progressionRosaria Gangemi, Valentina Mirisola, Gaia Barisione, et al.
Scientific Reports|September 23, 2018
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]Guido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
Scientific Reports|March 1, 2019
Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapyGuido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
BMC Cancer|June 17, 2015
TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survivalLucia Micale, Carmela Fusco, Andrea Fontana, et al.
Journal of Neuro-Oncology|May 4, 2023
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumorsElisabetta Lazzarini, Domenico Alessandro Silvestris, Giuseppe Benvenuto, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|January 21, 2014
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.
International Journal of Cancer|December 12, 2018
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastomaLindi Chen, Fabio Pastorino, Philip Berry, et al.
International Journal of Cancer|August 6, 2014
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019Donatella Vecchio, Antonio Daga, Elisa Carra, et al.
BMC Cancer|April 18, 2015
In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumorsFederica Barbieri, Stefano Thellung, Alessandra Ratto, et al.
The Journal of Biological Chemistry|January 17, 2009
Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitorsFabrizio Griffero, Antonio Daga, Daniela Marubbi, et al.
Plos One|January 24, 2012
Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progressionRosaria Gangemi, Valentina Mirisola, Gaia Barisione, et al.
Scientific Reports|September 23, 2018
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]Guido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
Scientific Reports|March 1, 2019
Author Correction: Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapyGuido Frosina, Jean Louis Ravetti, Renzo Corvò, et al.
BMC Cancer|June 17, 2015
TRIM8 downregulation in glioma affects cell proliferation and it is associated with patients survivalLucia Micale, Carmela Fusco, Andrea Fontana, et al.
Journal of Neuro-Oncology|May 4, 2023
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumorsElisabetta Lazzarini, Domenico Alessandro Silvestris, Giuseppe Benvenuto, et al.
Pageof 8